Evidence map›Paper›PMID 30992366›Full record

ArticleThe Journal of biological chemistry2019

Selective cleavage of fibrinogen by diverse proteinases initiates innate allergic and antifungal immunity through CD11b.

Cameron T Landers, Hui-Ying Tung, J Morgan Knight, Matthew C Madison, Yifan Wu, Zhimin Zeng, Paul C Porter, Antony Rodriguez, Matthew J Flick, Farrah Kheradmand and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Deconstructing fibrin(ogen) structure.Journal of thrombosis and haemostasis : JTH · 2025
    Review
  5. Article
  6. The emerging role of fibrin(ogen) in cardiovascular disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. STAT6 Blockade AbrogatesFrontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Cameron T LandersFrom the Translational Biology and Molecular Medicine Program.
Hui-Ying TungMedicine.
J Morgan KnightMedicine.
Matthew C MadisonFrom the Translational Biology and Molecular Medicine Program.
Yifan WuMedicine.
Zhimin Zengthe Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China, and.
Paul C PorterMedicine.
Antony RodriguezMedicine.
Matthew J Flickthe Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Research Foundation, Cincinnati, Ohio 45229.
Farrah KheradmandFrom the Translational Biology and Molecular Medicine Program, farrahk@bcm.edu.
David B CorryFrom the Translational Biology and Molecular Medicine Program, dcorry@bcm.edu.ORCID 0000-0001-9729-1016
Baylor College of Medicine · USMichael E. DeBakey VA Medical Center · USCincinnati Children's Hospital Medical Center · USSun Yat-sen University · CNTexas Medical Center · US

Funding

Immunology Scientist Training ProgramT32AI053831 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B · 2003 to 2018
$4.2M
Pathogenesis of Polymicrobial Cerebritis-Related DementiaR01AI135803 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B, KHERADMAND, FARRAH · 2018 to 2022
$3.8M
Th1 and Th17 Mediators in Experimental EmphysemaR01HL117181 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B, KHERADMAND, FARRAH · 2013 to 2016
$1.5M
Carbon Black Induced Activation of Lung APCsI01BX002221 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI CORRY, DAVID B · 2013 to 2016
–
BLRD VA I01 BX002221NHLBI NIH HHS R01 HL117181NIAID NIH HHS R01 AI135803NIAID NIH HHS T32 AI053831
6 · The paper itself

Abstract

Proteinases are essential drivers of allergic airway disease and innate antifungal immunity in part through their ability cleave the clotting factor fibrinogen (FBG) into fibrinogen cleavage products (FCPs) that signal through Toll-like receptor 4 (TLR4). However, the mechanism by which FCPs engage TLR4 remains unknown. Here, we show that the proteinases from

Indexed as

Immunity, InnateAnimalsAspergillusCD11b AntigenDisease Models, AnimalFibrinogenFungal ProteinsHypersensitivityMiceMice, Inbred C57BLMice, KnockoutPeptide HydrolasesProtein BindingProtein DomainsProtein SubunitsToll-Like Receptor 4CD11b AntigenFibrinogenFungal ProteinsItgam protein, mousePeptide HydrolasesProtein SubunitsToll-Like Receptor 4allergyfibrinogenfungiinnate immunityintegrinproteinaseToll-like receptor 4 (TLR4)

Identifiers

PMID30992366
PMCPMC6552423
OpenAlexW2936609048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.